US Bancorp’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,207
Closed -$61.6K 4403
2024
Q4
$61.6K Sell
1,207
-72
-6% -$3.54K ﹤0.01% 2639
2024
Q3
$52.7K Sell
1,279
-314
-20% -$15.1K ﹤0.01% 2710
2024
Q2
$76.7K Buy
1,593
+256
+19% +$11.3K ﹤0.01% 2463
2024
Q1
$64.2K Sell
1,337
-8
-0.6% -$427 ﹤0.01% 2569
2023
Q4
$87.3K Sell
1,345
-185
-12% -$11.1K ﹤0.01% 2405
2023
Q3
$100K Buy
1,530
+155
+11% +$9.75K ﹤0.01% 2150
2023
Q2
$79.9K Sell
1,375
-67
-5% -$4.23K ﹤0.01% 2299
2023
Q1
$89K Buy
1,442
+17
+1% +$1.02K ﹤0.01% 2249
2022
Q4
$90.6K Sell
1,425
-176
-11% -$12.8K ﹤0.01% 2240
2022
Q3
$117K Sell
1,601
-208
-11% -$15.5K ﹤0.01% 2132
2022
Q2
$123K Buy
1,809
+251
+16% +$18K ﹤0.01% 2125
2022
Q1
$141K Buy
1,558
+82
+6% +$6.71K ﹤0.01% 2124
2021
Q4
$135K Sell
1,476
-400
-21% -$34.3K ﹤0.01% 2152
2021
Q3
$152K Buy
1,876
+182
+11% +$15.3K ﹤0.01% 2078
2021
Q2
$158K Buy
1,694
+275
+19% +$26.7K ﹤0.01% 2070
2021
Q1
$152K Buy
1,419
+65
+5% +$6.74K ﹤0.01% 2049
2020
Q4
$118K Buy
+1,354
New +$95.6K ﹤0.01% 2138

Other funds holding NARI

US Bancorp's NARI Position: Q1 2025 in Review

US Bancorp sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,207 shares — an estimated $61.6K sold.

US Bancorp first reported a position in NARI in Q4 2020 and held it in 17 quarters. The position peaked at $158K in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • US Bancorp reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 1,207 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $61.6K.
  • US Bancorp first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • US Bancorp's Inari Medical, Inc. Common Stock position peaked at $158K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.